2022 ACR指南：糖皮质激素诱发性骨质疏松症的预防和治疗
发布日期：
2023-10-16
英文标题：
2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
制定者：
出处：
Arthritis Rheumatol.2023 Oct 16.
摘要：
糖皮质激素(GCs)仍然是多种疾病患者的常用治疗方式。由于骨质疏松性骨折的发病率和死亡率增加，预防糖皮质激素引起的骨质流失和骨折一直是美国风湿病学会（ACR）关注的焦点。本文主要更新了接受糖皮质激素治疗时间>3个月，剂量≥2.5 mg /天的风湿病和非风湿病患者的糖皮质激素诱发性骨质疏松症的预防和治疗建议。
展开部分内容仅可在
临床指南app 查看下载
阅读免费指南
发送到邮箱
收藏
分享
评论
提交评论
bearhong
2023.10.19
回复
这个app真的可以帮助我更好地了解医疗行业
/ 没有更多了 /
上传者信息
香芋
于2023-10-18上传
编者信息
美国风湿病学会
The American College of Rheumatology's mission is advancing rheumatology. The organization is for physicians, health professionals, and scientists that meets the mission through programs of education, research, advocacy and practice support. The ACR provides professional education for its members through several venues. The Annual Scientific Meeting, held each fall, is the premier scientific meeting devoted to the rheumatic diseases. This meeting draws thousands of rheumatologists and arthritis health professionals from around the world. A winter rheumatology symposium, spring clinical meetings, and other topical conferences round out the ACR's educational offerings.
置顶
